In conclusion, for individuals with type 2 diabetes, tirzepatide treatment, compared with semaglutide, significantly improved achievement of guideline-recommended standard and intensive therapeutic goals, potentially enhancing long-term prognosis
The GLP-1s that were originally marketed as a diabetes treatment include semaglutide, brand name Ozempic, liraglutide, brand name Victoza, dulaglutide, brand name Trulicity, and the latest GLP-1 to the market, tirzepitide, brand name Mounjaro, which is a combination GIP/GLP-1
Since caudatin is quickly absorbed, preferentially taken up by the liver, and has a favorable safety profile, it connects centuries of traditional medicine to modern therapeutics
Ultimately, a significant amount of the orally ingested vitamins and micronutrients is lost, and only small amounts pass to the rest of the body